If your horizon is sufficiently long, the dual tailwinds of an aging population and scientific advancement ought to blow through any obstacles.
Agreed. It's a bit rich at present, but for the reasons you've mentioned, Stryker Corp. and Medtronic probably have a steady, long growth climb in front of them. I think medical devices may be less problematic than drugs for a while.
Market Data 
Markets 
AI
